| Gene symbol | STAT3 | Synonyms | ADMIO, ADMIO1, APRF, HIES | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q21.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | signal transducer and activator of transcription 3 | ||||
| GTO ID | GTC1418 |
| Trial ID | NCT01563302 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | STAT3 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 481464|IONIS-STAT3Rx|AZD9150|Danvatirsen |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Phase 1/2 Study of ISIS 481464, an Antisense Oligonucleotide Inhibitor of STAT3, Administered to Patients With Advanced Cancers |
| Year | 2012 |
| Country | United States |
| Company sponsor | Ionis Pharmaceuticals, Inc. |
| Other ID(s) | ISIS 481464-CS1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||